COVID-19
coronavirus disease 2019 caused by SARS-CoV-2 - HRM&C Library:
COVID-19 Science and /versus Practice by dr Z Halat, MD, Medical
Epidemiology Consultant HEALTH RISK MANAGEMENT & COMMUNICATION HEALTH RISK MANAGEMENT & COMMUNICATION wariant polski COVID-19 coronavirus disease 2019 caused by SARS-CoV-2 Novel Coronavirus (2019-nCoV later named SARS-CoV-2) CHINESE DISEASE 中国疾病
HEALTH RISK MANAGEMENT & COMMUNICATION LIBRARY
Different Covid-19 Vaccines
We May Never Get to Herd Immunity
Swiss delay AstraZeneca COVID vaccine approval, order more shots from others
UK
Medicines & Healthcare products Regulatory Agency (MHRA) Decision
Conditions of Authorisation for COVID-19 Vaccine AstraZeneca Updated 28
January 2021
COVID-19
Vaccine AstraZeneca Product Information as approved by the Committee
for Medicinal Products for Human Use (CHMP) on 29 January 2021, pending
endorsement by the European Commission Includes: Package leaflet (for
patients) Summary of product characteristics (for healthcare
professionals) Manufacturers and conditions of the marketing
authorisation Labelling
How COVID-19 Vaccine AstraZeneca works
"COVID-19 Vaccine AstraZeneca is
expected to work by preparing the body to defend itself against
infection with the coronavirus SARS-CoV-2. This virus uses proteins on
its outer surface, called spike proteins, to enter the body’s cells and
cause disease.
COVID-19 Vaccine AstraZeneca is made up of another virus (of the
adenovirus family) that has been modified to contain the gene for
making the SARS-CoV-2 spike protein. The adenovirus itself cannot
reproduce and does not cause disease. Once it has been given, the
vaccine delivers the SARS-CoV-2 gene into cells in the body. The cells
will use the gene to produce the spike protein. The person’s immune
system will treat this spike protein as foreign and produce natural
defences − antibodies and T cells − against this protein.
If, later on, the vaccinated person comes into contact with SARS-CoV-2,
the immune system will recognise the virus and be prepared to attack
it: antibodies and T cells can work together to kill the virus, prevent
its entry into the body’s cells and destroy infected cells, thus
helping to protect against COVID-19."
Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide
COVID-19 CHINESE DISEASE: Total
Cases per Million and Total Deaths per Million, Available Data on April
25, 2020
COVID-19 CHINESE DISEASE: Total
Tests per Thousand and Total Cases per Million, Available Data on May
1, 2020, x = SARS CoV-2 Total Tests, y = COVID-19 Total Cases